Lilly(Eli) & Co (LLY)

Company Profile

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.

Company profile

Ticker

LLY

Exchange

NYSE

Website

www.lilly.com/

CEO

David Ricks

Incorporated

Indiana

Location

Indiana

Fiscal year end

Dec 31

Sector

Manufacturing > Pharmaceutical Preparation Manufacturing

Industry (SIC)

Pharmaceutical Preparations

Pfizer • Johnson & Johnson • Merck & Co • Teva- Pharmaceutical Industries • Bristol-Myers Squibb • Viatris • Abbvie • Bausch Health Companies • Celgene • Royalty Pharma ...

Former names

LILLY ELI & CO, LILLY ELI & CO ET AL

SEC CIK

0000059478

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Akouos, Inc. • Alnara Pharmaceuticals, Inc. • Andean Technical Operations • ARMO Biosciences, Inc. • Avid Radiopharmaceuticals, Inc. • CoLucid Pharmaceuticals, Inc. • Compania Farmaceutica Eli Lilly de Centro America SA • Dermira, Inc. • Disarm Therapeutics Inc. • Dista Ilac Ticaret Limited ...

IRS number

350470950

LLY stock data

1M 1Y 5Y

Analyst ratings and price targets

Last 3 months

Average target

$522.86

Low target

$430.00

High target

$560.00

Latest filings (excl ownership)

View all

SC TO-T/A

Third party tender offer statement (amended)

10 Aug 23

SC TO-T/A

Third party tender offer statement (amended)

8 Aug 23

Lilly Reports Second-Quarter 2023 Financial Results, Highlights Accelerating Revenue Growth and Key Pipeline Advancements

8 Aug 23

SC TO-T/A

Third party tender offer statement (amended)

1 Aug 23

SC TO-T/A

Third party tender offer statement (amended)

25 Jul 23

SC TO-T/A

Third party tender offer statement (amended)

18 Jul 23

SC TO-T/A

Third party tender offer statement (amended)

17 Jul 23

SC TO-T

Third party tender offer statement

13 Jul 23

SC TO-T

Third party tender offer statement

30 Jun 23

Transcripts

View all

LLY

Earnings call transcript

2023 Q2

8 Aug 23

LLY

Earnings call transcript

2023 Q1

27 Apr 23

LLY

Earnings call transcript

2022 Q4

2 Feb 23

LLY

Earnings call transcript

2022 Q3

1 Nov 22

LLY

Earnings call transcript

2022 Q2

4 Aug 22

LLY

Earnings call transcript

2022 Q2

7 Jun 22

LLY

Earnings call transcript

2022 Q1

28 Apr 22

LLY

Earnings call transcript

2021 Q4

3 Feb 22

LLY

Earnings call transcript

2021 Q3

26 Oct 21

LLY

Earnings call transcript

2021 Q2

3 Aug 21

Latest ownership filings

View all

Notice of proposed sale of securities

12 Sep 23

Change in insider ownership

8 Sep 23

144

Notice of proposed sale of securities

7 Sep 23

Financial summary

Financial statements Chart LLY financial data

Quarter (USD)	Jun 23	Mar 23	Dec 22	Sep 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21	Dec 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	2.69 bn	2.69 bn	2.69 bn	2.69 bn	2.69 bn	2.69 bn
Cash burn (monthly)	283.80 mm	(no burn)	(no burn)	(no burn)	(no burn)	(no burn)
Cash used (since last report)	798.10 mm	n/a	n/a	n/a	n/a	n/a
Cash remaining	1.90 bn	n/a	n/a	n/a	n/a	n/a
Runway (months of cash)	6.7	n/a	n/a	n/a	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2023

LLY institutional ownership history Ownership history

70.5% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	2663	2533	+5.1%
Opened positions	283	147	+92.5%
Closed positions	153	212	-27.8%
Increased positions	1013	1029	-1.6%
Reduced positions	1017	964	+5.5%

13F shares	Current	Prev Q	Change
Total value	312.89 tn	229.52 tn	+36.3%
Total shares	669.54 mm	725.99 mm	-7.8%
Total puts	6.49 mm	5.05 mm	+28.6%
Total calls	5.78 mm	4.94 mm	+17.2%
Total put/call ratio	1.1	1.0	+9.7%

Largest owners	Shares	Value	Change
Vanguard	69.92 mm	$32.79 tn	-0.1%
BLK Blackrock	64.45 mm	$30.23 tn	-1.7%
PNC PNC Financial Services	51.87 mm	$24.33 tn	-0.1%
STT State Street	33.88 mm	$15.89 tn	+1.9%
FMR	32.80 mm	$15.38 tn	+2.5%
Capital World Investors	26.87 mm	$12.60 tn	-2.6%
T. Rowe Price	24.16 mm	$11.28 tn	+6.3%
Primecap Management	23.55 mm	$11.04 tn	-7.2%
State Farm Mutual Automobile Insurance	17.36 mm	$8.11 tn	-0.3%
Geode Capital Management	15.21 mm	$7.11 tn	+2.3%

Largest transactions	Shares	Bought/sold	Change
Ofi Invest Asset Management	144.90 k	-52.89 mm	-99.7%
Wellington Management	14.45 mm	-5.87 mm	-28.9%
JPM JPMorgan Chase & Co.	14.14 mm	+3.23 mm	+29.6%
BMO Bank of Montreal	1.95 mm	+1.95 mm	NEW
Primecap Management	23.55 mm	-1.82 mm	-7.2%
Envestnet Asset Management	656.30 k	-1.78 mm	-73.0%
Mizuho Markets Americas	0.00	-1.77 mm	EXIT
Massachusetts Financial Services	2.67 mm	+1.67 mm	+168.4%
T. Rowe Price	24.16 mm	+1.44 mm	+6.3%
BLK Blackrock	64.45 mm	-1.12 mm	-1.7%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

LLY insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
18 Sep 23	Alvarez Ralph	Common Stock	Grant	Acquire A	No	No	571.28	20	11.43 k	53,379
18 Sep 23	J Erik Fyrwald	Common Stock	Grant	Acquire A	No	No	571.28	17	9.71 k	71,368
18 Sep 23	Hedley Mary Lynne	Common Stock	Grant	Acquire A	No	No	571.28	17	9.71 k	1,035
18 Sep 23	Kimberly H Johnson	Common Stock	Grant	Acquire A	No	No	571.28	17	9.71 k	2,181
18 Sep 23	Luciano Juan R	Common Stock	Grant	Acquire A	No	No	571.28	25	14.28 k	15,133